Qventus Announces $105 Million Investment, Series D Led by KKR
Qventus, an AI-based care automation software provider, announced a $105 million Series D investment led by KKR, with participation from Bessemer Venture Partners and new strategic investors such as Northwestern Medicine, HonorHealth, and Allina Health. This funding aims to expand Qventus' AI Operational Assistants platform across more clinical operations, building on its existing solutions like Surgical Growth and Inpatient Capacity.
Qventus' platform reduces administrative inefficiencies, enhances productivity by up to 50%, and has saved health systems millions of dollars. In the past year, their Inpatient Capacity solution eliminated over 36,000 excess days, and their Surgical Growth solution generated $95 million in annualized contribution margin for 2024. The company also reported a 35% increase in robotic surgeries using its technology.
The investment will help Qventus accelerate the development of new AI solutions, increase team productivity, and expand its global reach. The company recently received a KLAS score of 92.5% and Frost & Sullivan's Best Practices Customer Value Leadership Award for its high ROI solutions.
Qventus, un fornitore di software per l'automazione delle cure basato su AI, ha annunciato un investimento di 105 milioni di dollari nella Serie D, guidato da KKR, con la partecipazione di Bessemer Venture Partners e nuovi investitori strategici come Northwestern Medicine, HonorHealth e Allina Health. Questo finanziamento mira ad espandere la piattaforma di Assistenti Operativi AI di Qventus in ulteriori operazioni cliniche, costruendo sulle sue soluzioni esistenti come Surgical Growth e Inpatient Capacity.
La piattaforma di Qventus riduce le inefficienze amministrative, aumenta la produttività fino al 50% e ha fatto risparmiare milioni di dollari ai sistemi sanitari. Nell'ultimo anno, la loro soluzione Inpatient Capacity ha eliminato oltre 36.000 giorni di degenza in eccesso, e la loro soluzione Surgical Growth ha generato 95 milioni di dollari in margine di contribuzione annuale per il 2024. L'azienda ha anche riportato un aumento del 35% nelle operazioni chirurgiche robotiche utilizzando la sua tecnologia.
L'investimento aiuterà Qventus ad accelerare lo sviluppo di nuove soluzioni AI, aumentare la produttività del team e ampliare la sua portata globale. Recentemente, l'azienda ha ricevuto un punteggio KLAS del 92,5% e il Best Practices Customer Value Leadership Award di Frost & Sullivan per le sue soluzioni ad alto ROI.
Qventus, un proveedor de software de automatización del cuidado basado en IA, anunció una inversión de 105 millones de dólares en una ronda Serie D liderada por KKR, con la participación de Bessemer Venture Partners y nuevos inversores estratégicos como Northwestern Medicine, HonorHealth y Allina Health. Esta financiación tiene como objetivo expandir la plataforma de Asistentes Operativos de IA de Qventus en más operaciones clínicas, basándose en sus soluciones existentes como Surgical Growth e Inpatient Capacity.
La plataforma de Qventus reduce las ineficiencias administrativas, mejora la productividad hasta en un 50% y ha ahorrado millones de dólares a los sistemas de salud. En el último año, su solución Inpatient Capacity eliminó más de 36,000 días de estancia excesiva, y su solución Surgical Growth generó 95 millones de dólares en margen de contribución anual para 2024. La empresa también reportó un aumento del 35% en cirugías robóticas utilizando su tecnología.
La inversión ayudará a Qventus a acelerar el desarrollo de nuevas soluciones de IA, aumentar la productividad del equipo y expandir su alcance global. Recientemente, la empresa recibió una puntuación KLAS del 92.5% y el premio Best Practices Customer Value Leadership de Frost & Sullivan por sus soluciones de alto ROI.
Qventus는 AI 기반의 헬스케어 자동화 소프트웨어 제공업체로, KKR이 주도하고 Bessemer Venture Partners 및 Northwestern Medicine, HonorHealth, Allina Health와 같은 새로운 전략적 투자자들이 참여한 1억 500만 달러 규모의 D 라운드 투자를 발표했습니다. 이 자금은 기존의 Surgical Growth 및 Inpatient Capacity와 같은 솔루션을 기반으로 Qventus의 AI 운영 보조 플랫폼을 더 많은 임상 운영으로 확장하는 것을 목표로 하고 있습니다.
Qventus의 플랫폼은 관리 비효율성을 줄이고 생산성을 최대 50%까지 향상시키며, 의료 시스템에 수백만 달러를 절감했습니다. 지난 1년 동안, 그들의 Inpatient Capacity 솔루션은 36,000일 이상의 초과 입원을 제거했으며, Surgical Growth 솔루션은 2024년에 대한 연간 기여 마진으로 9,500만 달러를 창출했습니다. 이 회사는 또한 자사의 기술을 사용하여 로봇 수술이 35% 증가했다고 보고했습니다.
이번 투자는 Qventus가 새로운 AI 솔루션 개발을 가속화하고 팀 생산성을 높이며 글로벌 범위를 확장하는 데 도움을 줄 것입니다. 최근 이 회사는 92.5%의 KLAS 점수와 Frost & Sullivan의 최고의 관행 고객 가치 리더십 상을 수상했습니다.
Qventus, un fournisseur de logiciel d'automatisation des soins basé sur l'IA, a annoncé un investissement de 105 millions de dollars lors d'un tour de financement de série D mené par KKR, avec la participation de Bessemer Venture Partners et de nouveaux investisseurs stratégiques tels que Northwestern Medicine, HonorHealth et Allina Health. Ce financement vise à étendre la plateforme d'assistants opérationnels en IA de Qventus à davantage d'opérations cliniques, en s'appuyant sur ses solutions existantes telles que Surgical Growth et Inpatient Capacity.
La plateforme de Qventus réduit les inefficacités administratives, améliore la productivité jusqu'à 50% et a permis d'économiser des millions de dollars aux systèmes de santé. Au cours de l'année passée, leur solution Inpatient Capacity a éliminé plus de 36 000 jours excédentaires, et leur solution Surgical Growth a généré 95 millions de dollars de marge de contribution annualisée pour 2024. L'entreprise a également signalé une augmentation de 35% des interventions chirurgicales robotiques grâce à sa technologie.
Cette investissement aidera Qventus à accélérer le développement de nouvelles solutions AI, à augmenter la productivité de l'équipe et à élargir sa portée mondiale. Récemment, l'entreprise a obtenu un score KLAS de 92,5% et le prix de leadership en valeur client des meilleures pratiques de Frost & Sullivan pour ses solutions avec un retour sur investissement élevé.
Qventus, ein Anbieter von KI-gestützter Software für die Automatisierung von Pflegeprozessen, gab eine Investition von 105 Millionen Dollar in der Serie D bekannt, angeführt von KKR, mit Beteiligung von Bessemer Venture Partners und neuen strategischen Investoren wie Northwestern Medicine, HonorHealth und Allina Health. Diese Finanzierung zielt darauf ab, die Plattform von Qventus für KI-Betriebsassistenten in weiteren klinischen Bereichen auszubauen, basierend auf bestehenden Lösungen wie Surgical Growth und Inpatient Capacity.
Die Plattform von Qventus reduziert administrative Ineffizienzen, steigert die Produktivität um bis zu 50% und hat den Gesundheitssystemen Millionen von Dollar gespart. Im vergangenen Jahr hat ihre Lösung Inpatient Capacity über 36.000 überflüssige Tage eliminiert, und ihre Lösung Surgical Growth erzielte einen jährlichen Beitragsmargen von 95 Millionen Dollar für 2024. Das Unternehmen meldete zudem einen Anstieg der robotergestützten Chirurgien um 35% durch den Einsatz seiner Technologie.
Die Investition wird Qventus helfen, die Entwicklung neuer KI-Lösungen zu beschleunigen, die Teamproduktivität zu steigern und die globale Reichweite zu erweitern. Das Unternehmen erhielt kürzlich eine KLAS-Bewertung von 92,5% und den Best Practices Customer Value Leadership Award von Frost & Sullivan für seine Lösungen mit hohem ROI.
- $105 million Series D investment led by KKR
- Expansion of AI Operational Assistants platform
- Inpatient Capacity solution eliminated 36,000 excess days
- Surgical Growth solution generated $95M in annualized contribution margin for 2024
- 35% increase in robotic surgeries using Qventus technology
- KLAS score of 92.5%
- Frost & Sullivan's Best Practices Customer Value Leadership Award
- None.
Insights
KKR's
Qventus' impressive metrics are particularly compelling - their surgical growth solution generated
Qventus' AI platform addresses critical pain points in healthcare operations, demonstrated by concrete results: 36,000 excess days eliminated and optimization of over 500,000 surgeries. The 35% increase in robotic cases showcases the platform's ability to maximize utilization of high-value medical equipment. The platform's expansion beyond surgical and inpatient solutions indicates strong product evolution and market penetration potential.
The strategic value proposition is clear - healthcare systems struggle with administrative inefficiencies costing billions annually. By achieving up to 50% productivity improvements through AI automation, Qventus directly impacts both operational costs and care delivery quality. The participation of major health systems as strategic investors suggests strong industry validation and potential for accelerated adoption.
This investment validates the maturation of AI applications in healthcare operations. Qventus' decade-long data engine development creates significant barriers to entry, while their AI Operational Assistants represent a shift from traditional automation to more sophisticated, predictive interventions. The platform's ability to analyze and optimize complex workflows across different care settings demonstrates advanced AI capabilities beyond simple task automation.
The expansion into new care settings suggests scalable AI architecture and robust underlying technology. The focus on reducing administrative burden through AI teammates represents a practical application of AI that avoids the regulatory complexities of clinical decision-making while delivering measurable economic benefits. This positions Qventus favorably in the competitive healthcare AI landscape.
- The Company is a leading AI solutions provider across inpatient and outpatient operations, continuing to drive millions of dollars in ROI for health systems partners for over a decade
- The investment supports development and expansion of first-to-market AI Operational Assistants, extending the platform even further across clinical operations
Qventus has built an AI-first care operations automation platform deployed across leading health systems in inpatient and outpatient settings. This funding accelerates the Company’s ability to provide AI-based automations and AI operational assistants in more care settings, building upon the success of its existing offerings like Qventus’ Surgical Growth and Inpatient Capacity solutions as well as new solutions built on its first-to-market AI Operational Assistants platform capability.
Hospital executives, providers, and frontline staff are overburdened by manual, fragmented, and antiquated processes, which create challenges to achieving their mission of providing excellent care to patients in their communities. Despite having top-of-the-line therapies, clinicians and equipment, healthcare systems are hindered by inefficiencies related to administrative tasks like scheduling, higher costs, and more, which collectively cost the healthcare system billions of dollars every year. In turn, reducing staff burnout from administrative tasks and enhancing productivity have become mission-critical for health systems. Qventus’ transformative solutions and AI teammates help health systems combat these challenges by intelligently automating operations and end-to-end workflows across care settings.
“Across the country, healthcare teams have to do extraordinary things to get ordinary things done every single day. Qventus has dedicated the last decade to building AI automation solutions that alleviate the administrative burden of healthcare staff so they can deliver highly reliable patient care. This funding is a testament to how these solutions generate best-in-industry return on investment, helping health systems achieve the margins needed to fulfill their mission of delivering exceptional care to their communities,” said Mudit Garg, CEO and Co-Founder of Qventus. “This capital primes us to continue maximizing our growth, delivering on our promises to our partners, and launching new, game-changing technology.”
Qventus will leverage this funding to accelerate the development and commercialization of solutions powered by its AI Operational Assistants into new care settings beyond its Surgical Growth and Inpatient Capacity solutions. Enhancing team productivity by up to 50 percent, these AI teammates work alongside care teams to reduce the administrative burden, identify potential issues upstream, surface suggested interventions, and take action to solve problems for busy staff.
“Built on a solid foundation, Qventus has navigated the evolving care landscape and emerged resilient, thanks to its sophisticated technology and proprietary data engine built over the last decade,” said Jake Heller, Partner and Head of Tech Growth Equity,
Since its inception in 2012, Qventus has built a suite of AI solutions to address health system pain points across care settings. In the last year alone, Qventus’ Inpatient Capacity solution, which reduces the length of stay and creates capacity, eliminated over 36,000 excess days for its health system partners, saving them millions of dollars and helping them create the capacity to serve more patients in their communities. The company’s Surgical Growth solution drives strategic surgical volume for hospitals, generating
“By collaborating with Qventus, Northwestern Medicine has been able to significantly address capacity and access demands for our operating rooms which has allowed our patients quicker access to care,” said Doug King, Senior Vice President and Chief Information Officer, Northwestern Medicine. “By deploying Qventus’ solutions, Northwestern Medicine is able to reduce the burden on our clinical teams and allow them to turn their focus to caring for our patients.”
This financing follows a year of significant growth for Qventus, increasing its cadre of health system partners and expanding its team globally. The company received an impressive overall KLAS score of 92.5 percent (as of November 1, 2024) in the capacity management segment, in which 100 percent of customers included Qventus as a part of their long-term plans. Last month, Qventus additionally took home Frost & Sullivan’s Best Practices Customer Value Leadership Award for its commitment to providing best-in-class solutions that generate an average of over 10x return on investment for its hospital and health system clients.
KKR is funding this investment primarily from its Next Generation Technology III Fund.
Wilson Sonsini Goodrich & Rosati, P.C. served as legal advisor to Qventus, Latham & Watkins LLP served as legal advisor to KKR and Wilson Sonsini Goodrich & Rosati served as legal advisor to Bessemer Venture Partners.
About Qventus
For more than a decade, Qventus has been at the forefront as a provider of AI-based software automating care operations in both OR and inpatient settings. By deeply understanding the challenges faced by healthcare providers and applying modern technologies and principles proven in other industries, we empower care teams to make smarter decisions and optimize patient flow, while reducing the cognitive load on team members and improving the patient experience. Our solutions not only deliver meaningful returns but have also recently achieved the highest KLAS rating, creating a competitive edge for our clients, including health systems, independent hospitals, and academic medical centers. By integrating with EHRs, the Qventus platform leverages GenerativeAI, machine learning, and behavioral science to predict operational bottlenecks, recommend remedies, and automate processes. Explore more at www.qventus.com.
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at www.globalatlantic.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113993134/en/
Qventus
qventus@solcomms.co
KKR
Emily Cummings
media@kkr.com
Source: Qventus
FAQ
What is the significance of KKR's $105 million investment in Qventus?
How will Qventus use the $105 million investment from KKR?
What impact has Qventus' Inpatient Capacity solution had on healthcare systems?
How has Qventus' Surgical Growth solution benefited hospitals?
What recognition has Qventus received for its AI solutions?
Who participated in Qventus' $105 million Series D investment round?
What is the ROI generated by Qventus' AI solutions for health systems?
